06 September 2021>: Articles
A Rare Case of Factor VII Inhibitor in a Patient Presenting with Primary Splenic Marginal Zone Lymphoma
Rare disease
Kendra Naismith C , Pat A. Allevato B , Caroline Hamm A*DOI: 10.12659/AJCR.932704
Am J Case Rep 2021; 22:e932704
Figure 2. Plot of international normalized ratio (INR) and platelet counts. INR and platelet counts displayed over the first 2 months after initial presentation. The dashed lines indicated the first 2 rituximab treatments.